Surgical Hemostats Market Size & Growth Forecast 2027–2036, By Segments (Formulation, End-use, Product Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Surgical Hemostats Market size was around USD 3.79 Billion in 2026 and is slated to grow at 5.94% CAGR from 2027 to 2036, surpassing USD 6.75 Billion by 2036. The industry revenue for 2027 is estimated at USD 3.98 Billion.
Get more details on this report
Request Free Sample ReportSurgical Hemostats Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through advanced surgical infrastructure, high procedural volumes, sophisticated hospital systems, and widespread adoption of technologies supporting effective bleeding control and surgical efficiency.
- Asia Pacific is expanding rapidly through healthcare infrastructure investment, growing surgical capacity, minimally invasive procedure adoption, specialist training, and improved access to medical technologies.
Segment Momentum
- Matrix & gel hemostats held a 42.55% market share in 2026 because they conform to irregular wound surfaces, provide rapid bleeding control, and improve procedural efficiency across a wide range of surgical applications.
- Ambulatory surgical centers are growing rapidly as outpatient procedures and minimally invasive surgeries increase, driving demand for efficient, easy-to-use hemostatic products that support faster recovery and cost-effective care.
Market Expansion Drivers
- Rising global surgical procedure volumes driving consistent demand for hemostasis products
- Increasing trauma and accident cases boosting emergency surgical intervention needs
- Advancements in bioactive and absorbable hemostat technologies improving surgical outcomes
Leading Market Participants
- Prominent companies in the surgical hemostats market include Johnson & Johnson (Ethicon) (USA), Baxter International Inc. (USA), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Teleflex Incorporated (USA), Becton, Dickinson and Company (USA), Stryker Corporation (USA), Integra LifeSciences Holdings Corporation (USA), Gelita Medical GmbH (Germany), Pfizer Inc. (USA)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.79 Billion
- 2027 Estimated Market Size: USD 3.98 Billion
- Projected Market Size: USD 6.75 Billion by 2036
- Growth Forecast: 5.94% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Matrix & Gel Hemostats (Formulation) | Hospitals (End-use) | Oxidized Regenerated Cellulose-Based Hemostats (Product Type) | Orthopedic Surgery (Application)
- Emerging Opportunity Segment: Powder Hemostats (Formulation) | Ambulatory Surgical Centers (End-use) | Gelatin-based Hemostats (Product Type) | Cardiovascular Surgery (Application)
Market Growth Drivers and Industry Trends
Rising global surgical procedure volumes driving consistent demand for hemostasis products
The increasing number of surgical procedures performed across multiple medical specialties is creating sustained demand for products that support effective bleeding control during operations. This trend will drive the surgical hemostats market growth as healthcare providers prioritize reliable hemostatic solutions that improve surgical efficiency and help maintain clear operative fields. Hospitals and surgical centers are also expanding inventories of advanced hemostasis products to support a broad range of routine and complex procedures.
Increasing trauma and accident cases boosting emergency surgical intervention needs
The growing incidence of traumatic injuries resulting from road accidents, workplace incidents, and other emergencies has intensified the need for rapid surgical treatment in acute care settings. The surgical hemostats market is supported by this demand because emergency procedures frequently require immediate and effective bleeding management to stabilize patients and facilitate surgical intervention. Trauma centers and emergency departments increasingly rely on specialized hemostatic products that assist clinicians in controlling blood loss during time-sensitive operations.
Advancements in bioactive and absorbable hemostat technologies improving surgical outcomes
Continuous innovation in surgical materials is leading to the development of bioactive and absorbable hemostatic products that enhance bleeding control while integrating more effectively with natural healing processes. These technological advances will boost the surgical hemostats market by expanding the availability of solutions that improve handling characteristics, reduce the need for additional interventions, and support a wide variety of surgical applications. Manufacturers are also introducing products with enhanced biocompatibility and application flexibility to meet the evolving requirements of modern surgical practice.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global surgical procedure volumes driving consistent demand for hemostasis products | 2% | High | North America, Europe | High | Near Term |
| Increasing trauma and accident cases boosting emergency surgical intervention needs | 1.9% | High | Asia Pacific, Latin America | High | Near Term |
| Advancements in bioactive and absorbable hemostat technologies improving surgical outcomes | 1.6% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest position in the surgical hemostats market in 2026, supported by advanced surgical infrastructure, high procedural volumes, and widespread adoption of technologies designed to improve bleeding control during complex operations. The region benefits from strong demand for minimally invasive and advanced surgical procedures across cardiovascular, orthopedic, general, and other specialties, where effective hemostasis is essential for patient safety and surgical efficiency. Well-established hospital systems and access to sophisticated operating-room technologies encourage the use of topical and mechanical hemostatic solutions. In addition, continued clinical innovation and emphasis on reducing surgical complications and improving procedural outcomes are supporting the integration of advanced hemostatic products into routine surgical practice.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market as healthcare infrastructure expands and access to advanced surgical procedures improves across developing economies. Increasing investment in hospitals, growing surgical capacity, and rising healthcare awareness are creating broader opportunities for hemostatic products. The gradual adoption of minimally invasive techniques is also increasing the need for reliable bleeding-control solutions, particularly in facilities upgrading their surgical capabilities. Improvements in specialist training and medical technology access, combined with the expansion of private healthcare services, are further encouraging adoption. As healthcare systems place greater emphasis on surgical quality and patient outcomes, demand for efficient hemostatic technologies is expected to strengthen across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Surgical AdoptionThe U.S. surgical hemostats market is supported by broad adoption of advanced surgical procedures requiring reliable bleeding management. Healthcare providers continue evaluating products that improve procedural efficiency while fitting minimally invasive and complex surgical workflows.
Germany 🇩🇪
Precision Procedure SupportGermany emphasizes surgical hemostats that support precision across orthopedic, cardiovascular, and general surgical procedures. Hospitals are prioritizing clinically validated products that integrate smoothly into standardized operating room practices and procurement requirements.
Japan 🇯🇵
Quality-Focused Surgical CareJapan values surgical hemostats that deliver consistent performance during technically demanding procedures. Healthcare facilities are adopting products that support patient safety, procedural reliability, and efficient use within established clinical protocols across multiple specialties.
South Korea 🇰🇷
Minimally Invasive IntegrationSouth Korea is expanding the use of surgical hemostats alongside minimally invasive and technologically advanced surgical techniques. Medical institutions are seeking products that simplify intraoperative bleeding control while supporting efficient clinical outcomes and workflow optimization.
France 🇫🇷
Hospital Procurement FocusFrance places emphasis on surgical hemostats that demonstrate dependable clinical performance within structured hospital procurement systems. Suppliers are strengthening product portfolios with solutions that support surgeon preference while addressing operational efficiency in healthcare facilities.
Italy 🇮🇹
Specialty Surgery AlignmentItaly is adopting surgical hemostats across specialty procedures where effective bleeding management contributes to procedural consistency. Healthcare providers are evaluating versatile products suitable for different surgical disciplines while supporting established treatment practices.
Segment Leadership and Growth Trends
Surgical Hemostats Market Share (%), by Formulation, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportFormulation Segment Analysis: Matrix & Gel Hemostats (Largest Segment) vs Powder Hemostats (Fastest-Growing Segment)
Holding the largest share of the surgical hemostats market, matrix & gel hemostats accounted for 42.55% in 2026. Their widespread adoption is attributed to their ability to conform to irregular wound surfaces, provide rapid bleeding control, and perform effectively in complex surgical procedures. These formulations are extensively utilized across multiple surgical specialties because they are easy to apply and help improve procedural efficiency while minimizing blood loss. The increasing volume of advanced surgical interventions and growing emphasis on effective intraoperative bleeding management continue to support the segment's leading position.
The powder hemostats segment is expected to witness the fastest growth, driven by increasing demand for versatile hemostatic agents that can be applied quickly in challenging surgical environments. Powder formulations offer broad coverage over bleeding surfaces and are particularly useful in minimally invasive and difficult-to-access procedures. Ongoing product innovation and the rising adoption of advanced surgical techniques are expected to accelerate demand for powder hemostats across healthcare settings.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
The hospitals segment dominated the market with a share of 50.77% in 2026, reflecting the high concentration of complex surgical procedures performed in these facilities. Hospitals possess advanced operating infrastructure, specialized surgical teams, and comprehensive postoperative care capabilities, making them the primary users of surgical hemostatic products. The growing number of major surgical interventions and continued investment in advanced surgical technologies further reinforce the segment's dominant position.
In the surgical hemostats market, ambulatory surgical centers are anticipated to register the fastest growth due to the increasing shift toward outpatient surgical care. These facilities are expanding their procedural capabilities while emphasizing efficiency, shorter recovery times, and cost-effective treatment delivery. As minimally invasive surgeries become more common, demand for reliable and easy-to-use hemostatic products within ambulatory surgical centers is expected to increase steadily.
Product Type Segment Analysis: Oxidized Regenerated Cellulose-Based Hemostats (Largest Segment) vs Gelatin-based Hemostats (Fastest-Growing Segment)
The oxidized regenerated cellulose-based hemostats segment accounted for the largest share of 21.89% in 2026, supported by its proven effectiveness in controlling bleeding across a broad range of surgical procedures. These products are widely preferred because they are absorbable, easy to handle, and compatible with different surgical techniques, enabling surgeons to achieve reliable hemostasis while reducing procedural complexity. Their established clinical acceptance and extensive use across multiple specialties continue to sustain the segment's leadership.
The gelatin-based hemostats segment is projected to record the fastest growth in the surgical hemostats market, driven by increasing demand for highly adaptable hemostatic solutions suitable for diverse surgical applications. Their excellent absorbency, compatibility with combination therapies, and effectiveness in managing complex bleeding situations have expanded their utilization in modern operating rooms. Continued advancements in surgical practices and rising demand for efficient bleeding control solutions are expected to support sustained segment growth.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Formulation | Matrix & Gel Hemostats, Sponge Hemostats, Sheet & Pad Hemostats, Powder Hemostats | Matrix & Gel Hemostats | Powder Hemostats |
| End-use | Clinics, Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Product Type | Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-based Hemostats, Combination Hemostats, Others | Oxidized Regenerated Cellulose-Based Hemostats | Gelatin-based Hemostats |
| Application | General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynecological Surgery, Neurosurgery, Reconstructive Surgery, Others | Orthopedic Surgery | Cardiovascular Surgery |
Competitive Landscape and Market Positioning
Major players in the surgical hemostats market:
- Johnson & Johnson (Ethicon) (USA)
- Baxter International, Inc. (USA)
- Medtronic plc (Ireland)
- B. Braun Melsungen AG (Germany)
- Teleflex Incorporated (USA)
- Becton Dickinson and Company (USA)
- Stryker Corporation (USA)
- Integra LifeSciences Holdings Corporation (USA)
- Gelita Medical GmbH (Germany)
- Pfizer, Inc. (USA)
Clinical effectiveness is increasingly defining competitive advantage in the surgical hemostats market as healthcare providers place greater emphasis on products that deliver reliable bleeding control across a wide range of surgical procedures and patient conditions. Manufacturers are directing innovation toward materials with enhanced handling characteristics, faster application, and improved compatibility with minimally invasive techniques, reflecting changing surgical practices rather than incremental product refinement alone. At the same time, the need to satisfy rigorous clinical evidence requirements and evolving regulatory expectations is raising barriers to differentiation, encouraging sustained investment in product validation, physician education, and procedure-specific solutions that align with modern operating room workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson (Ethicon) (USA) | |||||||
| Baxter International Inc. (USA) | |||||||
| Medtronic plc (Ireland) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Teleflex Incorporated (USA) | |||||||
| Becton Dickinson and Company (USA) | |||||||
| Stryker Corporation (USA) | |||||||
| Integra LifeSciences Holdings Corporation (USA) | |||||||
| Gelita Medical GmbH (Germany) | |||||||
| Pfizer Inc. (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Ethicon | Nov-23 | Secured CE mark approval for the ETHIZIA Hemostatic Sealing Patch, an adjunctive hemostat solution indicated for managing bleeding on internal organs excluding neurological and cardiovascular applications. This regulatory milestone strengthens the company's European market positioning and expands its advanced wound closure product offerings. |
| Teleflex Corporation | Aug-23 | Received U.S. Food and Drug Administration clearance for the QuikClot Control+ Hemostatic Device, designed to manage bleeding during cardiac surgical procedures. This regulatory approval expands the company's commercialized surgical portfolio and enhances its operational capabilities in the cardiovascular hemostasis segment. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Surgical Hemostats Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Absorbability | Absorbable Hemostats, Non-Absorbable Hemostats |
| Procurement Model | Direct Procurement, Distributor Procurement, Group Purchasing Organization Procurement |
| Surgical Access Route | Open Surgery, Minimally Invasive Surgery, Endoscopic Surgery |
Surgical Hemostats Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Procedure-Specific Hemostat Adoption |
|
| Hospital Procurement & Formulary Dynamics |
|
| Surgical Workflow Integration |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of surgical hemostats?
How is the surgical hemostats industry projected to perform over the next decade?
How are rising surgical procedure volumes influencing the surgical hemostats market?
Why are technological advances in hemostats becoming strategically important?
Why do matrix & gel hemostats lead the surgical hemostats market?
Why are ambulatory surgical centers the fastest-growing end-use segment in the surgical hemostats market?
Why does North America lead the surgical hemostats market?
How is Asia Pacific driving faster growth in surgical hemostats?
Which organizations are considered leaders in the surgical hemostats landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization